Fragmented QRS and Neutrophil-to-Lymphocyte Ratio as Noninvasive Biomarkers of Lymphovascular Space Invasion in Endometrial Cancer: A Retrospective Cohort Study

Öz

Objective To evaluate the prognostic significance of fragmented QRS (fQRS) on electrocardiography and the neutro- phil-to-lymphocyte ratio (NLR) as noninvasive bio- markers in endometrial cancer, with particular focus on their association with lymphovascular space inva- sion (LVSI). Material and Method In this retrospective cohort study, 198 patients who underwent surgery for endometrial cancer were in- cluded. All cases were staged according to the 2023 FIGO classification. Preoperative complete blood counts and electrocardiograms were assessed to de- termine NLR and the presence of fQRS. Clinicopath- ological variables, including LVSI status, were record- ed and statistically analyzed. Results The median NLR was significantly higher in patients with fragmented QRS compared with those with- out fragmented QRS (2.45 [1.46–12.42] vs. 2.04 [0.66–7.72], p = 0.013). LVSI positivity was observed more frequently among patients with fQRS (30% vs. 11.3%, p = 0.007). ROC curve analysis identified an optimal NLR cut-off value of 2.4 for predicting substan- tial LVSI (AUC = 0.62, 95 % CI: 0.55–0.69, p = 0.013), with a sensitivity of 64.3% and specificity of 58.2%. Multivariable logistic regression analysis demonstrat- ed that higher BMI (OR: 1.07, 95% CI: 1.01–1.14, p = 0.031), smoking (OR: 2.84, 95% CI: 1.18–6.84, p = 0.020), hypertension (OR: 0.38, 95% CI: 0.15–0.96, p = 0.041), and LVSI positivity (OR: 3.21, 95% CI: 1.24– 8.31, p = 0.016) were independently associated with the presence of fragmented QRS. Conclusion Both fQRS and NLR were associated with LVSI in pa- tients with endometrial cancer and may reflect adverse pathological features related to tumor aggressiveness. However, these findings should be considered explor- atory, and further prospective studies are required be- fore clinical implementation can be recommended.

Anahtar Kelimeler

• Endometrial cancer
• Fragmented QRS
• Lymphovascular space invasion
• Neutrophil-to-lymphocyte ratio
• Prognostic biomarker

Destekleyen Kurum

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Etik Beyan

Ethical approval was obtained from the Institutional Ethics Committee (AESH-BADEK2) with the approval number 2025-414. The study was conducted in accordance with the principles of the Declaration of Helsinki. Due to the retrospective design of the study, the requirement for informed consent was waived by the ethics committee.

Teşekkür

The authors would like to thank all healthcare professionals involved in the management of the patients included in this study.

Kaynakça

1. 1. Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Wor- ldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209-249. doi:10.3322/caac.21660
2. 2. Boothe D, Wolfson A, Christensen M, et al. Lymphovascular Invasion in Endometrial Cancer: Prognostic Value and Impli- cations on Adjuvant Radiation Therapy Use. Am J Clin Oncol. 2019;42(7):549-554. doi:10.1097/COC.0000000000000559
3. 3. Berek JS, Matias-Guiu X, Creutzberg C, et al. FIGO staging of endometrial cancer: 2023. Int J Gynecol Obstet. 2023;162:383- 394. doi:10.1002/ijgo.14923
4. 4. Njoku K, Ramchander NC, Wan YL, et al. Pre-treatment inf- lammatory parameters predict survival from endometrial cancer: A prospective database analysis. Gynecol Oncol. 2022;164(1):146-153. doi:10.1016/j.ygyno.2021.11.009
5. 5. Aoyama T, Takano M, Miyamoto M, et al. Pretreatment Neutrophil-to-Lymphocyte Ratio Was a Predictor of Lymph Node Metastasis in Endometrial Cancer Patients. Oncology. 2019;96(5):259-267. doi:10.1159/000497184
6. 6. Dong Y, Cheng Y, Wang J. The Ratio of Neutrophil to Lymp- hocyte is a Predictor in Endometrial Cancer. Open Life Sci. 2019;14:110-118. doi:10.1515/biol-2019-0012
7. 7. Muangto T, Maireang K, Poomtavorn Y, et al. Study on Preope- rative Neutrophil/Lymphocyte (NLR) and Platelet/Lymphocyte Ratio (PLR) as a Predictive Factor in Endometrial Cancer. Asi- an Pac J Cancer Prev. 2022;23(10):3317-3322. doi:10.31557/ APJCP.2022.23.10.3317
8. 8. Li Q, Kong F, Ma J, et al. Nomograms Based on Fibrinogen, Albumin, Neutrophil-Lymphocyte Ratio, and Carbohydrate Anti- gen 125 for Predicting Endometrial Cancer Prognosis. Cancers (Basel). 2022;14(22):5632. doi:10.3390/cancers14225632

9. 9. Cong R, Kong F, Ma J, et al. Combination of preoperative neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and mo- nocyte-lymphocyte ratio: a superior prognostic factor of en- dometrial cancer. BMC Cancer. 2020;20(1):464. doi:10.1186/ s12885-020-06953-8
10. 10. Sadeghi R, Dabbagh VR, Tayyebi M, et al. Diagnostic value of fragmented QRS complex in myocardial scar detection: syste- matic review and meta-analysis of the literature. Kardiol Pol. 2016;74(4):331-337. doi:10.5603/KP.a2015.0193
11. 11. Supreeth RN, Francis J. Fragmented QRS – Its significance. In- dian Pacing Electrophysiol J. 2020;20(1):27-32. doi:10.1016/j. ipej.2019.12.005
12. 12. NCCN Clinical Practice Guidelines in Oncology: Uterine Neop- lasms. Version 2.2023. Plymouth Meeting, PA: National Comp- rehensive Cancer Network. Available at: https://www.nccn.org/ professionals/physician_gls/pdf/uterine.pdf
13. 13. Colombo N, Creutzberg C, Amant F, et al. ESMO-ESGO-EST- RO Endometrial Consensus Conference Working Group. ES- MO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up. Ann Oncol. 2016 Jan;27(1):16-41. doi:10.1093/annonc/mdv484
14. 14. Çetin M, Kocaman SA, Erdoğan T, et al. The independent relationship of systemic inflammation with fragmented QRS complexes in patients with acute coronary syndromes. Korean Circ J. 2012 Jul;42(7):449-57. doi: 10.4070/kcj.2012.42.7.449. Epub 2012 Jul 26. PMID: 22870078; PMCID: PMC3409393.
15. 15. Dural M, Demir L, Babayiğit E, et al. Fragmented QRS forma- tion and its predictors in patients with breast cancer receiving anthracycline-based chemotherapy. J Electrocardiol. 2019 May-Jun;54:5-9. doi: 10.1016/j.jelectrocard.2019.02.003. Epub 2019 Feb 12.
16. 16. Cetin AS, Cetin S, Dokmetas I. Evaluation of Relationship between fQRS and CD4/CD8 Ratio in Patients with HIV. Sisli Etfal Hastan Tip Bul. 2021 Jul 2;55(2):247-252. doi: 10.14744/ SEMB.2020.12980.